Excimer Laser Trabeculostomy (ELT)
No major surgery. Fewer drops. No implants.
The next step of treating Glaucoma is near. We have secured 22 patents over a 20 year period and we are ready to implement the robotic procedure to increase Trabeculostomy operations by 300%.
Advantages of Excimer Laser Trabeculostomy
Minimally invasive (MIGS)
No foreign bodies implanted
Sustained lower IOP
No hypotony
No pressure spikes
Non-thermal UV tissue removal
Minimizes risk of scarring
Preserves limbal tissue
If ever needed for future procedures
No blebs created
Performed in ¼ the time of trabeculectomy
With significantly less post-op monitoring needed
Excimer Laser Trabeculostomy (ELT)
No major surgery. Fewer drops. No implants.
The next step of treating Glaucoma is near. We have secured 22 patents over a 20 year period and we are ready to implement the robotic procedure to increase Trabeculostomy operations by 300%.
Excimer Laser Trabeculostomy (ELT)
First clinically proven (1998), minimally invasive, long lasting MIGS solution for the treatment of open-angle glaucoma.
ELT effectively and consistently lowers IOP & medications in the long-term (5 years).
Being stealth and minimally invasive, the procedure creates no discomfort for patients.
How It Works
A 200 μm fiberoptic probe is introduced through a paracentesis to contact trabecular meshwork & deliver non-thermal 308nm XeCl excimer laser energy to excise the trabecular meshwork, juxtacanalicular trabecular meshwork, & the inner wall of Schlemm’s canal without damaging the outer wall or collector channels.
Essentially, ELT is the "LASIK"-like procedure of the trabelucar meshwork. The benefits for patients are spectacular: when tissue is converted into gas, it leaves no scarring. The recovery time is just 1-2 weeks (compared with up to 10 week with other treatment options)
The Procedure
The ELT procedure was developed and patented by Michael Berlin, M.D. and was first used clinically in 1998. The procedure has been used in Europe for over ten years on more than 4,000 patients, and has proven successful.
EyeLight’s ELT System treats open-angle glaucoma by restoring the natural outflow process in the eye. This is accomplished by re-establishing the eye’s drainage channels between the Trabecular Meshwork and Schlemm's Canal, which drains the aqueous fluid produced in the eye. This process treats glaucoma without creating an undesirable disruption to the eye’s outer surface (as with Trabeculectomy), without any implanted stents, and has shown to be superior in sustained lowering of intraocular pressure (IOP). The procedure is diagrammed and detailed below:
Step 1
EyeLight’s ELT uses an access method identical to cataract surgery, familiar to ophthalmic surgeons.
Step 2
ELT Probe contacts the Trabecular Meshwork and non-thermal laser energy is applied to remove the outflow obstruction without causing scarring.
Step 3
Physician creates a series of controlled outflow openings.
Step 4
EyeLight’s ELT eliminates the outflow obstruction in the Trabecular Meshwork, re-establishing the natural outflow, thus lowering pressure.